OBJECTIVE: Investigating the effects of coenzyme Q10 on organ damage and survival on mice in cecal ligation perforation (CLP) model in sepsis. BACKGROUND: Coenzyme Q10 is an antioxidant molecule playing an important role in mitochondria. Mitochondrial dysfunction is an important mechanism in sepsis pathophysiology. METHODS: Nintyfour Swiss Albino male mice were divided into 8 groups. CLP was performed in Group I. Coenzyme Q10, 100 mg/kg subcutaneously, was given 5 hours after CLP to Group II and 20 hours after CLP to Group III. Sham operation was performed in Group IV, 100 mg/kg coenzyme Q10 subcutaneously was given 5 hours after sham operation to Group V and 20 hours after sham operation to Group VI. No operation was performed in Group VII; coenzyme Q10, 100 mg/kg subcutaneously, was given to Group VIII. Antibiotics and fl uid replacement were applied for 3 days. The mice still living were sacrifi ced at 576th hour. The organ damages were scored under light microscopy. RESULTS: The survival of Group I and Group II was lower than that of the control groups, but the survival in the Group III was similar to control groups. It was established that spleen, kidney, heart damage and total organ damage were decreased when compared to CLP group. CONCLUSIONS: Coenzyme Q10 is effective in decreasing histological organ damage in sepsis (Tab. 3. Fig. 1 , Ref. 30). Text in PDF www.elis.sk.
Introduction
Sepsis, a systemic infl ammatory response to infection, is an important cause of death in intensive care units. Only in United States approximately 215000 patients die from sepsis each year (1) . It is known that energy-metabolism disturbances during sepsis are characterized by enhanced glycolytic fl uxes and reduced mitochondrial respiration (2) . High mortality (60-80 %) in sepsis is caused by proinfl ammatory cytokines and various early and late mediators.
A mitochondrial network in neutrophils was recently described besides the primary role of neutrophils in pathophysiology of acute sepsis. Mitochondria play an essential role in cellular viability and metabolism. Mitochondria have important roles in intracellular energy generation, modulation of apoptosis, and redox-dependent intracellular signaling. Initial studies indicated that modulation of mitochondrial membrane potentially infl uences neutrophil chemotaxis (3) . In addition, mitochondria produce large amounts of reactive oxygen species (ROS) which is involved in eradication of bacteria and other pathogens. However, excessive production of ROS by neutrophils can be deleterious, contributing to organ system dysfunction in infl ammatory conditions, such as sepsis or acute lung injury (4) . Recently in a review study the importance of mitochondria-targeted antioxidants in sepsis was emphasized (5) .
Mitochondrial dysfunction has been identifi ed in various animal models. Hypertrophic mitochondria have been encountered in the livers of patients dying from severe sepsis, which have been attributed to a decrease in Complex I-IV activity.
In this study, a hypothesis was put forward proposing that mitochondrial enzymes might constitute a potential treatment option in sepsis, if oxidative stress directed to the mitochondria plays a central role in the pathophysiology of sepsis. For this reason, it was thought that the coenzyme Q10 might be a treatment option. Coenzyme Q10, a mitochondrial coenzyme, has an antioxidative effect due to its electron transfer ability. It has gained popularity nowadays due to its antioxidative and anti-infl ammatory roles especially in cardiac diseases and hypertension. The levels of important proinfl ammatory cytokines such as IL-6 and TNF-alpha play signifi cant role in the development of congestive heart failure, acute myocardial infarction and hypertension. In many stud-ies, these cytokines have been shown to decrease noticeably as a result of oral coenzyme Q10 intake (6) .
It is known that many infl ammatory mediators are released during the development of sepsis (7) . The most frequently encountered metabolic state in sepsis is the increase in lactate levels. A possible cause for this might be activation of glycolysis, in association with mitochondrial dysfunction due to decreased coenzyme Q10 levels (2) .
Cecal ligation and perforation (CLP) is a preferred method to demonstrate systemic response to local infection. Peritonitis originating from the mixed intestinal fl ora is performed by perforation. In this model, the hyperdynamic and hypodynamic phases of sepsis are encountered at the 5th and 20th hour after ligation, respectively (8) .
This study aimed to evaluate the effects of coenzyme Q10 administration at the 5th and 20th hour on organ damage and survival in mice on sepsis induced by cecal ligation and perforation.
Materials and methods
Experimental Animals Ethics Committee of the Hacettepe University Medical Faculty approved (2010/17-2) the procedures. Male Swiss albino mice (weighing between 20-40 g) were supplied from Animal Husbandry Facility of Hacettepe University. Mice were monitored at 22 ± 3 ºC and 30 % to 70 % relative humidity and with 12 hours dark / 12 hours bright cycles (with the time period from 7 am to 7 pm being bright). Mice were provided with tap water and standard laboratory animal feed (KorkutelimYem; Sanayi, Antalya, Turkey)
Experimental groups
Ninety-four Swiss Albino male mice were randomly divided into 8 groups. Group 1: CLP (n = 14) Group II: CLP -Coenzyme Q10 administeredd at 5th hour (n = 14) Group III: CLP -Coenzyme Q10 administered at 20th hour (n = 14) Group IV: Sham (n = 12) Group V: Sham -Coenzyme Q10 administered at 5th hour (n = 12) Group VI: Sham -Coenzyme Q10 administered at 20th hour (n = 12) Group VII: Control (n = 8) Group VIII: Control -Coenzyme Q10 present (n = 8)
After all of the mice were anesthetized with subcutaneous ketamine hydrochloride (Ketalar Flacon, Pfi zer, Istanbul) (80 mg/ kg) and subcutaneous xylazine (Alfazyne 2% Injectable, Alfasan International B.V. Holland) (16 mg/kg), peritonitis was introduced by the same general surgeon, with cecal ligation and perforation being applied.
Anesthetized mice were fi xed in supine position and their anterior abdominal wall was disinfected with ethanol. Peritoneum was entered through a 1 cm incision of the left lower quadrant. The cecum was located and its 1/3 distal section was tied with a 3-0 silk suture. The cecum was perforated at two points with the aid of a needle (20 G). A little amount of feces was removed from the cecum by slightly squeezing it. Cecum was introduced back into its original position in the peritoneum and the abdomen was closed with a 4-0 absorbable suture.
Cecum was introduced back into the abdomen without ligation and perforation in the sham control group. Three hours after the procedure, Ceftriaxone (Iesef injectable vial, I.E. Ulugay) at a dose of 30 mg/kg and clindamycin (Cleocin ampul, Eczacibaşi) at a dose of 30 mg/kg were administered intramuscularly every 8 hours for the following three days to all of the groups. Subcutaneous coenzyme Q10 (Coenzyme Q10, Sigma-Aldrich) was administered at a dose of 100 mg/kg at the 5 th postoperative hour to 3 of the groups; one of each CLP, Sham and Control groups, and also at the 20th hour to 2 of the groups; one of each, CLP and Sham groups.
For all of the groups, 0.045 NaCl solution was administered subcutaneously for fl uid replacement following ligation; it was administered at the 6th and 12th hour at a dose of 100 ml/kg and at a dose of 35 ml/kg every 6 hours after 18th hour for 3 days. In addition, tramadol (Contramal ampul, Abdi Ibrahim) 1 mL (20 mcg/g) was administered to all animals subcutaneously as an analgesic after cecal ligation and perforation procedure.
The mice were observed until they awake and were enumerated, and then taken to the location where they would be monitored. Their hourly mortality was followed. The death hours were recorded in all groups. Animals which were alive on the 24th day after cecal ligation and perforation were sacrifi ced with high dose of ketamine. The lung, heart, liver, kidney and spleen of the mice were isolated and fi xed in 10% formaldehyde.
Histopathological evaluation
Formalin-fi xed tissues were dehydrated through a graded ethanol series, cleared in xylene and embedded in paraffi n blocks by standard procedures. Five micrometer thick sections were stained with hematoxylin-eosin and Masson's trichrome according to standard protocols. The sections were examined and photographed by using a light microscope (Leica DM6000B, Wetzlar, Germany) with a DC490 digital camera (Leica, Wetzlar, Germany).
Two histologists, who were blinded to the experimental groups, examined the stained sections. The specimens were graded on a four-point scale ranging from 0 to 3 depending on whether the fi nding was absent: 0, mild: 1, moderate: 2, or severe: 3 (9) . The lung specimens were evaluated for the presence of pulmonary edema, congestion in the parenchyma, alveolar hemorrhage, peribronchial infl ammation, perivascular infl ammation, and interstitial infl ammation. The lung injury score was calculated by summing the scores of these six parameters (maximum score 18). The liver specimens were evaluated for the presence of ischemic necrosis, congestion in the parenchyma, hepatocellular injury, periportal infl ammation, and vacuolar degeneration. The liver injury score was calculated by summing the scores of these fi ve parameters (maximum score 15). Congestion, fi brosis and presence of giant cell were evaluated for spleen injury (maximum score 9). Kidney specimens were evaluated according to the presence of congestion and necrosis. Kidney injury score was calculated by adding the scores of these two parameters. The heart specimens were evaluated for the pres-ence of congestion in the parenchyma, necrosis and infi ltration in the parenchyma. Total organ injury score was calculated by adding these parameters (maximum score 54).
Statistical analysis
Statistical analysis was performed with the SPSS 16.0 program. The level of signifi cance was accepted as p < 0.05 in collective comparisons performed in the eight groups. Kolmogorov-Smirnov test was used to assess the distribution of the data. Numerical variables with normal distribution were given as mean ± SD. Groups were analyzed with ANOVA, while the t-test and Bonferroni corrections were used in post hoc comparisons. Data without normal distribution were expressed as median values (minimummaximum). The Kruskal-Wallis test was used for comparisons of nonparametric histopathological organ damage scores between all groups, while the Mann-Whitney U test was used for paired comparisons. In paired comparisons, p < 0.0017 was accepted as signifi cant.
Results
Nine of 14 mice in CLP group died before 576th hour and the survival rate was 35.7 %. The survival rate of this group was lower than control and control+ Q10 groups (p < 0.0017). There was no signifi cant difference when compared to other groups (Tab. 1). In CLP+5th hour Q10 group 10 mice died and the survival rate was 28.5 %; this rate was lower than Control and Control+Q10 groups (p < 0.0017) (Tab. 1). In CLP+20th hour Q10 group 7 mice died, survival rate of this group was 50 % (Tab. 1). This survival rate was similar to all groups (p > 0.0017).
Histopathological scores of organ injury are summarized in Table 2 and these histopathological changes in each group are shown in Figure 1 . An overall histopathological grade assigned to each sample was given in Table 3 . The total organ injury was significantly increased in CLP group compared to control, control+Q10, sham, sham+Q10 groups and CLP+20th Q10 group. The administration of Q10 to CLP group decreased the total organ injury scores. Decrease in the total organ injury score was statistically signifi cant in CLP+20th hour Q10 when compared to CLP.
Discussion
The current study which evaluated the effects of coenzyme Q10 on organ damage and survival in mice with sepsis induced through a cecal ligation and perforation model, it was observed that cecal ligation and perforation increased total lung, total liver, total spleen, total kidney and total heart damages compared to the sham and control groups. In previous studies, various histo-pathological fi ndings caused by sepsis had been demonstrated in the organs (10, 11, 12) . Interstitial and perivascular infl ammation in the lungs, vacuolar degeneration and damage in the liver, and increased organ damage in the spleen and kidney were reported in a study performed on mice with induced sepsis (9) . Histological results similar to previous studies have been demonstrated in our study by the CLP model. These fi ndings suggest that the CLP model was effective in our study.
Oxidative damage is one of the factors contributing to cellular damage, organ dysfunction and death (13) . Oxidative damage in mitochondria plays an important role in the pathophysiology of sepsis. Mitochondrial complexes decrease after the 18th hour following the cecal ligation and perforation method (14) . Evidence of mitochondrial damage at light microscopic level depends on intensity and duration of the event. Total organ injury in our study composed of histopathological criteria like edema, congestion, leukocyte infi ltration, cellular damage and necrosis are used in order to identify the effects of sepsis on organs at light microscopic level. In our study, for the group that received coenzyme Q10 at the 20th hour after CLP, total organ damage decreased and the survival rate approached the rate observed in the control groups. These fi ndings support the observations concerning the positive effects of coenzyme Q10 in sepsis through mitochondrial enzymes. It is known that coenzyme Q10 exerts a powerful antioxidant property by directly reacting with free radicals in the lysosome, the Golgi apparatus and the plasma membrane, in addition to the mitochondria (15) . Although the effi cacy of antioxidant support treatment for sepsis has not been suffi ciently determined yet, there are many studies in which positive results have been obtained with antioxidant treatment (16, 17, 18, 19) .
In a study by Lelli et al performed on dogs it was demonstrated that coenzyme Q10 supported cardiovascular hemodynamics and inhibited lipid peroxidation caused by free radicals during septic shock induced by viable E. coli models (20). In our current study it is believed that coenzyme Q10 administered in septic mice reduced oxidative stress and cytopathic hypoxia in the mitochondria by increasing the activity of the complexes on the mitochondrial membrane, and that coenzyme Q10 also exerted an anti-infl ammatory effect by decreasing the production of pro-infl ammatory cytokines and free oxygen radicals.
The time period between 2nd and 10th hour after CLP is defi ned as the early and hyperdynamic phase of sepsis. Late and hypodynamic phase of sepsis starts after the 16th hour from the CLP. The similarity of the damages observed in organs other than heart damage with the damage observed in the CLP group in animals administered with coenzyme Q10 at the 5th hour following CLP can be attributed to the increased tissue perfusion in the hyperdynamic phase. In a study investigating the changes in the heart and mito- chondrial function of rats in septic shock, it was demonstrated that decreased myocardial contractility was caused by mitochondrial dysfunction and energy defi ciency (21) . In this study, coenzyme Q10 displayed its effects on the mitochondria-rich heart tissue in the early period. The lower level of total spleen, kidney, heart and total organ damage observed in the CLP + Q10 group at the 20th hour in comparison to the CLP group can be attributed to the hypodynamic phase of sepsis. Thus, it is possible to say that coenzyme Q10 is effective in the late hypodynamic phase of sepsis. Certain studies defi ne fl uid resuscitation as the critical step for the formation of the early, hyperdynamic phase of sepsis (22, 23, 24) . A study had performed a comparison of mortality rates between mice with low (35 ml/kg during CLP), intermediate (35 ml/kg during CLP and every 6 hours afterwards), and high (100 ml/kg during CLP and 35 ml/kg every 6 hours afterwards) fl uid resuscitation, mortality rates were found to be lower in mice with high fl uid resuscitation (25) . In another study, the survival rate in mice with no treatment after CLP was 0 %, while the survival rate increased to 24 % by fl uid resuscitation alone, and to 30 % by antibiotic treatment alone (intramuscular ceftriaxone, 30 mg/kg; and intramuscular application of clindamycin, 30 mg/kg). This rate is closer to the survival rate observed in our study.
It has been reported that post-CLP mortality rates can change as a result of the implementation of different antibiotic use and fl uid resuscitation protocols (26) . In our study, the longer survival periods observed in some of the animals in the CLP group was 
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Spleen Injury Scores considered to be associated with adequate fl uid resuscitation and the use of appropriate antibiotic treatments. There is currently no consensus regarding the dose of coenzyme Q10 that should be used for animal studies. In a study on rats 10 and 100 mg/kg doses of Coenzyme Q10 were administered (27.) . There are certain studies in which coenzyme Q10 is administered to mice at a dose of 10 mg/kg (28) . In the study he conducted with dogs, Lelli administered coenzyme Q10 as a bolus dose of 20 mg/kg 10 minutes prior the commencement of bacterial infusion (17) . In a study involving oral coenzyme Q10 administration, Q10 was provided to mice at doses of 200 mg/kg/ day and 400 mg/kg/ day (29) . In another study evaluating the antioxidant and healing effects of coenzyme Q10 in mice, the Q10 dose was adjusted as 100 mg /kg (30) .
Certain publications report better clinical results with higher doses of coenzyme Q10 (6) . In our study, coenzyme Q10 was administered to the animals at the 5th and 20th hour as a single, high dose bolus after CLP was induced.
The vacuolar degeneration score for the liver as well as the total liver score were higher in the sham 20th hour coenzyme Q10 group in comparison to the sham group. It is not known how coenzyme Q10 interacts with the liver after surgery. In future studies, it might be necessary to closely monitor liver functions in humans during the post-surgical administration of coenzyme Q10. The absence of differences between the parameters of the Control and the Control+Q10 groups suggests that this effect of Coenzyme Q10 most likely arises in the presence of additional stress factor such as surgery or a SIRS triggering event. The absence of statistically signifi cant differences between the Sham and the Sham + 5th hour Q10 groups, and hence the lack of effects similar to the ones observed when coenzyme Q10 is administered at the 20th hour, suggests that this effect is time-dependent.
Coenzyme Q10 administration to mice with sepsis induced by CLP decreased organ damage and increased survival. But abscess formation and the progression of sepsis in the CLP model may vary in many different ways from the sepsis syndrome observed among humans. Therefore, it would not be possible for the results of the experiments performed on mice to be exactly the same with results that are applicable for different species and humans.
Another drug with antioxidant effects used in our study was ketamine, which was provided for inducing anesthesia. This antioxidant effect of ketamine might have suppressed the effects of CLP on the oxidative pathway. Nevertheless, ketamine was used in all of the groups, and it was hence concluded that ketamine would not engender any differences in the comparisons that were performed.
Because blood drawing changes mortality in mice; further studies are needed to evaluate the relationship between plasma cytokine levels and organ functions.
Survival rate of CLP group is lower compared to controls but there is no signifi cant difference when compared to sham groups; this is probably about the number of mice.
Conclusion
Coenzyme Q10 administered during the hypodynamic phase of sepsis especially decreases splenic, renal and cardiac damage and organ damage, and also increases the survival rate in mice. However, further experimental studies followed by clinical studies are necessary in order to elucidate coenzyme Q10's effective dose, treatment period, mechanism of action, as well as its role in the pathophysiology of sepsis. The lung injury score was calculated by adding the scores of pulmonary edema, congestion in the parenchyma, alveolar hemorrhage, peribronchial, perivascular and interstitial infl ammation (maximum score 18). The liver injury score was calculated by summing the scores of ischemic necrosis, congestion in the parenchyma, hepatocellular injury, periportal infl ammation, and vacuolar degeneration (maximum score 15). The congestion, fi brosis and presence of giant cell were evaluated for spleen injury (maximum score 9). The kidney specimens were evaluated according to the presence of congestion and necrosis (maximum score 6). The heart sp ecimens were evaluated for the p resence of congestion in the p arenchyma, necrosis and infi ltration in the p arenchyma (maximum 9). Total organ injury score was calculated by adding these p arameters (maximum score 54). Values are p resented as Mean ± SD, * When comp ared to CLP group p < 0.0017, # When comp ared to CLP +5th hour group p < 0.0017, º When comp ared to CLP +20th hour group p < 0.0017, ^ When comp ared to Sham group p < 0.0017, δ When comp ared to Sham+5th hour group p < 0.0017, ε When comp ared to Sham+20th hour group p < 0.0017, ∆ When comp ared to Control group p < 0.0017, ∞ When comp ared to Control+Q10 group p < 0.0017
Tab. 3. Total organ injury scores.

